Tonometry waveforms were signal-averaged using the electrocardiographic R-wave as a fiducial point. Systolic and diastolic cuff blood pressures obtained at the time of the tonometry acquisition were used to calibrate the peak and trough of the signal-averaged brachial pressure waveform. Diastolic and integrated mean brachial pressures were used to calibrate carotid pressure tracings.24 (link) Calibrated carotid pressure was used as a surrogate for central pressure.24 (link) Central pulse pressure was defined as the difference between the peak and trough of the calibrated carotid pressure waveform. Carotid-brachial pulse pressure amplification was defined as brachial pulse pressure divided by central pulse pressure. Augmentation index was computed from the carotid pressure waveform as previously described.25 (link) Carotid-femoral (aortic) and carotid-radial (muscular artery) pulse wave velocities were calculated from tonometry waveforms and body surface measurements, which were adjusted for parallel transmission in the brachiocephalic artery and aortic arch by using the suprasternal notch as a fiducial point.26 (link) The carotid-femoral transit path spans the aorta, making carotid-femoral PWV a measure of aortic stiffness. In contrast, the carotid-radial transit path spans the subclavian, brachial and radial arteries, making carotid-radial PWV a measure of muscular artery stiffness.
>
Physiology
>
Organism Function
>
Pulse Pressure
Pulse Pressure
Pulse Pressure is the difference between the systolic and diastolic blood pressure measurements.
It provides important information about the cardiovascular system's health and function.
Elevated pulse pressure is associated with increased risk of cardiovascular events, such as heart attack and stroke.
Optimizing pulse pressure research protocols is crucial for understanding this key physiological metric and developing effective treatments.
PubCompare.ai's AI expertise can help researchers seamlesly locate the best protocols from literature, preprints, and patents, and leverage advanced tools to identify the most effective protocols and products for their pulse pressure research needs.
It provides important information about the cardiovascular system's health and function.
Elevated pulse pressure is associated with increased risk of cardiovascular events, such as heart attack and stroke.
Optimizing pulse pressure research protocols is crucial for understanding this key physiological metric and developing effective treatments.
PubCompare.ai's AI expertise can help researchers seamlesly locate the best protocols from literature, preprints, and patents, and leverage advanced tools to identify the most effective protocols and products for their pulse pressure research needs.
Most cited protocols related to «Pulse Pressure»
Aorta
Aortic Stiffness
Arch of the Aorta
Arterial Stiffness
Arteries
Arteries, Radial
Carotid Arteries
Diastole
Electrocardiography
Femur
Measure, Body
Muscle Tissue
Pressure
Pressure, Diastolic
Pulse Pressure
Systole
Tonometry
Transmission, Communicable Disease
Trunks, Brachiocephalic
A-A-1 antibiotic
Aorta
Aortic Root
Arteries
Biological Evolution
Blood Vessel
Blood Volume
Circle of Willis
Diastole
PDN-1
Plant Roots
Pressure
Pressure, Diastolic
Pulse Pressure
Systole
Total Peripheral Resistance
Vascular Resistance
The subjects studied were all participants in the Howard University Family Study (HUFS), a population based family study of African Americans in the Washington metropolitan area. The major objectives of the HUFS were to: 1) enroll and examine a randomly ascertained cohort of African-American families, along with a set of unrelated individuals, from the Washington DC metropolitan area to study the genetic and environmental basis of common complex diseases including hypertension, obesity and associated phenotypes; 2) to characterize study participants for anthropometry (including weight, height, waist and hip circumferences, body composition measures) and BP; and 3) evaluate the association between genetic variants and selected traits (hypertension, BP and obesity). Participants were sought through door-to-door canvassing, advertisements in local print media and at health fairs and other community gatherings. In order to maximize the utility of this cohort for the study of multiple common traits, families were not ascertained based on any phenotype. During a clinical examination, demographic information was collected by interview. Weight, height, waist circumference and hip circumference were measured using standard methods as follows: Weight was measured in light clothes on an electronic scale to the nearest 0.1 kg, and height was measured with a stadiometer to the nearest 0.1 cm. Body mass index (BMI) was computed as weight in kg divided by the square of the height in meters. Waist circumference was measured to the nearest 0.1 cm at the narrowest part of the torso as seen from the anterior aspect. BP was measured in the sitting position using an oscillometric device (Omron). Three BP readings were taken with a ten minute interval between readings. The reported SBP and DBP readings were the average of the second and third readings. Pulse pressure (PP) was calculated as the difference between the SBP and DBP. Hypertension status was defined as SBP> = 140 mmHg and/or DBP> = 90 mmHg and/or treatment with antihypertensive medication. In the overall cohort, the frequency of hypertension was 35% and among those that were hypertensive, 64% were on antihypertensive medication at the time of the study.
Full text: Click here
African American
Antihypertensive Agents
Body Composition
Genetic Diversity
High Blood Pressures
Index, Body Mass
Light
Medical Devices
Obesity
Oscillometry
Pharmacotherapy
Phenotype
Physical Examination
Printed Media
Pulse Pressure
Reproduction
Torso
Vision
Waist Circumference
Aorta
Arterial Stiffness
Arteries
Arteries, Radial
Brachial Artery
Carotid Arteries
Diastole
Femur
Foot
Medical Devices
Pressure
Pulse Pressure
Pulse Rate
Rate, Heart
Reflex
Sphygmomanometers
Systole
Participants were asked to avoid exercise, tobacco, alcohol, caffeine and food-intake four hours before evaluation. All haemodynamic measurements were performed in a temperature-controlled environment (21–23°C), with the subject in supine position and after resting for at least 10–15 minutes. Heart rate (HR) and brachial pSBP and pDBP were recorded in supine position using the validated oscillometric device (HEM-433INT; Omron Healthcare Inc., Illinois, USA) simultaneously and/or immediately before or after each non-invasive tonometric(radial and carotid applanation tonometry [RT and CT], respectively] and brachial oscillometry [BOSC]) recording. Peripheral pulse pressure (pPP; pPP = pSBP–pDBP) and MBPc (MBPc = pDBP+pPP/3) were obtained.
Central BP and wave components (Pf and Pb) were assessed (random order) using two commercially available devices: SphygmoCor-CvMS (SCOR; v.9, AtCor-Medical, Australia) and Mobil-O-Graph PWA-monitor system(MOG; I.E.M.-GmbH, Stolberg, Germany) [Fig 1 ][9 ,10 (link),11 (link)]. Both devices and systems enable doing pulse wave analysis (PWA) and wave separation analysis (WSA)[6 (link),11 (link),12 (link),14 (link)].
Radial and carotid pressure waves were obtained by applanation tonometry with SCOR. The acquired waves were calibrated toMBPc and pDBP(HEM-433INT; Omron Healthcare Inc., Illinois, USA). Central BP waves were derived from radial recordings (using a GTF) and cSBP and cPP were quantified. Carotid artery pulse waves were assumed to be identical to the aortic ones (due to the proximity of the arterial sites). Thus, a GTF was not applied to obtain central waves from carotid records. Considering a triangular flow model (using WSA), Pf and Pb components of the obtained aortic waves were separated [2 ]. Only accurate waveforms on visual inspection and high-quality recordings (in-device quality index>75%) were considered.
Brachial BP levels and waveforms were obtained using the MOG (brachial cuff-based oscillometric device, BOSC)[21 (link)]. The device determined cBP levels and waveforms from peripheral recordings using a validated GTF. Then, by means of PWA and WSA, Pf and Pb were obtained[10 (link),14 (link)]. Only high quality records (index equal to 1 or 2) and satisfactory waves (visual inspection) were considered. A step-by-step explanation of the method used to carry out WSA based on recorded (carotid wave, SCOR) and mathematically-derived aortic waveform (SCOR and MOG) was included as Supplementary Material (S1 Appendix ). Absolute and relative intra (repeatability) and inter-observer (reproducibility) variability of cSBP, cPP, Pf and Pb was evaluated [Supplementary Material, S1 Appendix ]. No significant differences were observed in cSBP, cPP, Pf or Pb absolute levels either within each visit, between two records or between records obtained by investigators; indicating excellent repeatability, as well as reproducibility. In all cases, the relative inter- and intraobserver variability was <6%.
Central BP and wave components (Pf and Pb) were assessed (random order) using two commercially available devices: SphygmoCor-CvMS (SCOR; v.9, AtCor-Medical, Australia) and Mobil-O-Graph PWA-monitor system(MOG; I.E.M.-GmbH, Stolberg, Germany) [
Radial and carotid pressure waves were obtained by applanation tonometry with SCOR. The acquired waves were calibrated toMBPc and pDBP(HEM-433INT; Omron Healthcare Inc., Illinois, USA). Central BP waves were derived from radial recordings (using a GTF) and cSBP and cPP were quantified. Carotid artery pulse waves were assumed to be identical to the aortic ones (due to the proximity of the arterial sites). Thus, a GTF was not applied to obtain central waves from carotid records. Considering a triangular flow model (using WSA), Pf and Pb components of the obtained aortic waves were separated [2 ]. Only accurate waveforms on visual inspection and high-quality recordings (in-device quality index>75%) were considered.
Brachial BP levels and waveforms were obtained using the MOG (brachial cuff-based oscillometric device, BOSC)[21 (link)]. The device determined cBP levels and waveforms from peripheral recordings using a validated GTF. Then, by means of PWA and WSA, Pf and Pb were obtained[10 (link),14 (link)]. Only high quality records (index equal to 1 or 2) and satisfactory waves (visual inspection) were considered. A step-by-step explanation of the method used to carry out WSA based on recorded (carotid wave, SCOR) and mathematically-derived aortic waveform (SCOR and MOG) was included as Supplementary Material (
Full text: Click here
Aorta
Arm, Upper
Arteries
Caffeine
Carotid Arteries
Common Carotid Artery
Eating
Environment, Controlled
Ethanol
Hemodynamics
Medical Devices
Oscillometry
Pressure
Pulse Pressure
Pulse Rate
Pulse Wave Analysis
Rate, Heart
Tobacco Products
Tonometry
Most recents protocols related to «Pulse Pressure»
The primary objective included mediation analyses of each of the five placebo-controlled trials (Ferdinand et al., AWARD-1, AWARD-5, AWARD-8, and AWARD-10) followed by a meta-analysis pooling the individual mediation results in a random-effect model. In the mediation analyses, the total effect of dulaglutide 1.5 mg vs. Placebo was decomposed into a weight-dependent (i.e., mediated by weight) and weight-independent effect on changes from baseline for SBP, DBP, and pulse pressure. The total effect, weight-dependent effect, and weight-independent effect were estimated via a series of multiple regression models adjusted for covariates including baseline weight, baseline blood pressure, hypertension diagnosis at baseline, and study-specific covariates. To provide more perspective, we also report the estimated “% weight-independent” calculated as the percentage of weight-independent effect with respect to the total effect. A post-hoc sensitivity meta-analysis was completed without AWARD-8 as its background medication differs from other studies. The mediation analyses assumed no other unknown or unmeasured confounding factors besides the adjusted covariates. The computational details of the mediation analysis were provided in Additional file 1 : Supplemental Methods.
For the secondary objective, a mediation analysis for dose response was first conducted as described above on AWARD-11 for dulaglutide 4.5 mg vs. dulaglutide 1.5 mg. AWARD-11 also evaluated dulaglutide 3.0 mg vs. dulaglutide 1.5 mg, but these comparisons were not examined in the current report as there was less difference in SBP between dulaglutide 3.0 mg and dulaglutide 1.5 mg at week 26. An adjusted indirect comparison (Bucher method) [21 (link)] of dulaglutide 4.5 mg vs. placebo was then conducted using the mediation analysis results from AWARD-11 (4.5 mg vs. 1.5 mg) and AWARD-5 (1.5 mg vs. placebo), as these trials had similar background therapy (Additional file1 : Supplemental Methods). This analysis provided an estimation of the weight-dependent, weight-independent, and total effects of higher dose dulaglutide compared to placebo. A sensitivity analysis of the indirect comparison of dulaglutide 4.5 mg vs. placebo was also conducted that included a subset of participants from Ferdinand et al. which had similar background therapy as AWARD-11 and AWARD-5.
Analyses were based on the intention-to-treat populations from each study, excluding patients who discontinued study drug before 6 months. All analyses were exploratory: descriptive and mediation analysis (PROC CAUSALMED) was performed using SAS v9.4, and the meta-analysis (packages meta and metafor) and indirect comparison were performed using R v3.4.4.
For the secondary objective, a mediation analysis for dose response was first conducted as described above on AWARD-11 for dulaglutide 4.5 mg vs. dulaglutide 1.5 mg. AWARD-11 also evaluated dulaglutide 3.0 mg vs. dulaglutide 1.5 mg, but these comparisons were not examined in the current report as there was less difference in SBP between dulaglutide 3.0 mg and dulaglutide 1.5 mg at week 26. An adjusted indirect comparison (Bucher method) [21 (link)] of dulaglutide 4.5 mg vs. placebo was then conducted using the mediation analysis results from AWARD-11 (4.5 mg vs. 1.5 mg) and AWARD-5 (1.5 mg vs. placebo), as these trials had similar background therapy (Additional file
Analyses were based on the intention-to-treat populations from each study, excluding patients who discontinued study drug before 6 months. All analyses were exploratory: descriptive and mediation analysis (PROC CAUSALMED) was performed using SAS v9.4, and the meta-analysis (packages meta and metafor) and indirect comparison were performed using R v3.4.4.
Full text: Click here
Blood Pressure
Diagnosis
dulaglutide
High Blood Pressures
Hypersensitivity
Patients
Pharmaceutical Preparations
Placebos
Population Group
Pulse Pressure
Therapeutics
SPSS version 25.0 and GraphPad Prism 9.4.1 (681) were used for statistical analysis and plotting. Normally distributed continuous variables are presented as mean and standard deviation. Non-normally distributed continuous variables are presented as medians and interquartile ranges. Categorical variables are expressed as frequencies and percentages.
The independent sample t-test, the Mann–Whitney U test, and the chi-square test were used to compare the differences of continuous variables and categorical variables between the two groups. All variables with a significance level of P < 0.10 on the univariate test were included in further multivariate analyses. Three linear regression models were then developed. Model 1 was the basic model, including LVH and accepted demographic data (age, sex, BMI, and education level). Model 2 was adjusted for cardiovascular risk factors (diabetes mellitus, CVD, common CAS, smoking history, beta-blockers, pulse pressure, and EF) based on Model 1. Model 3 was adjusted for laboratory parameters (hemoglobin, albumin, hsCRP, and Ccr) based on Model 2. Next, the risk factors of CI were analyzed by multivariate logistic regression analysis.
To reduce the effect of possible selection bias, the effect of the small number of patients with LVH, and the effect of the relatively large number of associations on the reliability of the multivariable model and to adjust for the effects of other potential confounders without reducing the ratio of events per variable, we further performed sensitivity analyses for LVH by propensity score matching. Propensity score matching was performed using the following variables: age, sex, BMI, RRF, CVD, pulse pressure, and EF. The maximum difference in propensity scores that allowed matching was 0.02, and all test levels were two-sided, with P < 0.05 indicating statistical significance.
The independent sample t-test, the Mann–Whitney U test, and the chi-square test were used to compare the differences of continuous variables and categorical variables between the two groups. All variables with a significance level of P < 0.10 on the univariate test were included in further multivariate analyses. Three linear regression models were then developed. Model 1 was the basic model, including LVH and accepted demographic data (age, sex, BMI, and education level). Model 2 was adjusted for cardiovascular risk factors (diabetes mellitus, CVD, common CAS, smoking history, beta-blockers, pulse pressure, and EF) based on Model 1. Model 3 was adjusted for laboratory parameters (hemoglobin, albumin, hsCRP, and Ccr) based on Model 2. Next, the risk factors of CI were analyzed by multivariate logistic regression analysis.
To reduce the effect of possible selection bias, the effect of the small number of patients with LVH, and the effect of the relatively large number of associations on the reliability of the multivariable model and to adjust for the effects of other potential confounders without reducing the ratio of events per variable, we further performed sensitivity analyses for LVH by propensity score matching. Propensity score matching was performed using the following variables: age, sex, BMI, RRF, CVD, pulse pressure, and EF. The maximum difference in propensity scores that allowed matching was 0.02, and all test levels were two-sided, with P < 0.05 indicating statistical significance.
Full text: Click here
Adrenergic beta-Antagonists
Albumins
C Reactive Protein
Diabetes Mellitus
Hemoglobin
Hypersensitivity
Patients
prisma
Pulse Pressure
Demographic characteristics and complications were recorded, including age, sex, body mass index (BMI), education level, dialysis duration, systolic blood pressure, diastolic blood pressure, pulse pressure, smoking, diabetes mellitus, hypertension, primary kidney disease, and history of CVD. Education level was recorded as the highest school level for which a diploma was obtained: primary school or below, middle school, high school and beyond. Primary kidney disease includes chronic glomerulonephritis, diabetic nephropathy, and others (such as IgA nephropathy, nephrotic syndrome, lupus nephritis, Sjogren's syndrome, and ANCA-associated vasculitis). CVD information was obtained from medical history reviews, and CVD was recorded if any of the following conditions were present: angina pectoris, grade III or IV congestive heart failure (as classified based on the guidelines of the New York Heart Association), transient ischemic attack, myocardial infarction, and cerebrovascular accident.
Full text: Click here
Angina Pectoris
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Cerebrovascular Accident
Congestive Heart Failure
Diabetes Mellitus
Diabetic Nephropathy
Dialysis
Glomerulonephritis
Heart
High Blood Pressures
IGA Glomerulonephritis
Index, Body Mass
Kidney Diseases
Lupus Nephritis
Myocardial Infarction
Nephrotic Syndrome
Pressure, Diastolic
Pulse Pressure
Sjogren's Syndrome
Systolic Pressure
Transient Ischemic Attack
We extracted single nucleotide polymorphisms (SNP) of BP based on summary statistics in a genome-wide association study (GWAS) meta-analysis of 757,601 individuals from the International Consortium of Blood Pressure database and UK Biobank (Evangelou et al., 2018 (link)). In this study, BP traits incorporated systolic BP (SBP), diastolic BP (DBP), and pulse pressure (PP), which have been adjusted for AHM use by adding 15 and 10-mmHg to SBP and DBP, respectively. We restricted the set of SNPs to be significantly associated with the exposure with a p-value reaching genome-wide significance (p < 5 × 10–8), and the threshold of linkage disequilibrium (LD) was set at R2 = 0.001 using the 1,000 Genomes European reference panel. In addition, the above study adjusted effect estimates for body mass index (BMI), potentially introducing collider bias as BMI is causal for both elevated BP and PD, so a sensitivity analysis was performed using alternative UK Biobank GWAS summary statistics of SBP (N = 436419) and DBP (N = 436424) not adjusted for BMI(Mitchell et al., 2019 (link)).
Full text: Click here
Blood Pressure
Europeans
Genome
Genome-Wide Association Study
Hypersensitivity
Index, Body Mass
Pressure, Diastolic
Pulse Pressure
Single Nucleotide Polymorphism
Systole
Systolic Pressure
Participants sat in a quiet, dark room, 180 cm away from the center of a 24 modules custom-made array (Fig 1A ) spanning ± 36° of visual angle (with 0° being the center of the array, negative and positive values indicating leftward and rightward position, respectively). All testing procedures took place in total darkness so that the array was not visible to the participants, excluding the possibility that responses were influenced by contextual cues (such as the array’s silhouette). Each module could deliver either visual or auditory stimulation. Visual stimuli were red flashes with a diameter of 3° of visual angle at participant’s viewing position, while auditory stimuli were 2 kHz sine wave pulses with 60 dB Sound Pressure Level (SPL). Every module could deliver only one stimulus at a time, i.e., a module could produce either a sound or a flash, never both simultaneously (even though participants were unaware of that). The array was linked to the computer used to run the experiment through a USB cable. The connection between the array and the laptop was also powered via a dedicated host. The experiment was developed and run using MATLAB (v. 2013b).
Full text: Click here
Acoustic Stimulation
Auditory Perception
Darkness
DB 60
Pulse Pressure
Short Interspersed Nucleotide Elements
Sound
Top products related to «Pulse Pressure»
Sourced in Australia, United States
The SphygmoCor is a non-invasive medical device developed by AtCor Medical. Its core function is to measure and analyze the arterial pulse wave, providing insights into the cardiovascular system's health and function.
Sourced in Australia, United States
The SphygmoCor system is a non-invasive diagnostic device used to measure arterial stiffness and central blood pressure. It utilizes applanation tonometry to capture pressure waveforms from the radial artery, which are then analyzed to derive various parameters related to cardiovascular function.
Sourced in Japan
The HEM-9000AI is a blood pressure monitor that provides accurate and consistent blood pressure measurements. It features advanced sensors and algorithms to deliver reliable results.
Sourced in United States, United Kingdom, Germany, Canada, Japan, Sweden, Austria, Morocco, Switzerland, Australia, Belgium, Italy, Netherlands, China, France, Denmark, Norway, Hungary, Malaysia, Israel, Finland, Spain
MATLAB is a high-performance programming language and numerical computing environment used for scientific and engineering calculations, data analysis, and visualization. It provides a comprehensive set of tools for solving complex mathematical and computational problems.
Sourced in Australia, United States
The SphygmoCor XCEL is a medical device designed for the non-invasive measurement of central blood pressure and arterial stiffness. It utilizes applanation tonometry technology to capture peripheral pulse waveforms, which are then analyzed to derive central hemodynamic parameters.
Sourced in Australia, United States
The SphygmoCor XCEL system is a noninvasive device that measures central blood pressure and arterial stiffness. It uses applanation tonometry to capture arterial pressure waveforms, providing objective data on cardiovascular health.
Sourced in Australia
The SphygmoCor device is a non-invasive diagnostic tool designed to measure central blood pressure and arterial stiffness. It utilizes applanation tonometry technology to assess the mechanical properties of the cardiovascular system.
Sourced in Japan
The VaSera VS-1000 is a diagnostic device designed for vascular function assessment. It is capable of measuring various cardiovascular parameters, including ankle-brachial index and pulse wave velocity.
Sourced in Japan, United States, United Kingdom
The HEM-907XL is an automated blood pressure monitor designed for professional use in clinical settings. It is capable of measuring systolic and diastolic blood pressure, as well as pulse rate. The device features a large, easy-to-read display and is powered by AC adapter.
Sourced in Australia
The SphygmoCor XCEL device is a non-invasive diagnostic instrument designed to measure central blood pressure and arterial stiffness parameters. It utilizes applanation tonometry technology to acquire pulse waveforms from the radial artery and provides information about the cardiovascular system's function.
More about "Pulse Pressure"
Pulse pressure, the difference between systolic and diastolic blood pressure, is a crucial metric for understanding cardiovascular health.
Elevated pulse pressure is associated with increased risk of heart attacks, strokes, and other cardiovascular events.
Optimizing pulse pressure research protocols is essential for developing effective treatments.
Researchers can utilize various tools and technologies to measure and analyze pulse pressure.
The SphygmoCor system, for example, is a widely used device that provides accurate pulse pressure measurements.
The SphygmoCor XCEL and VaSera VS-1000 are other devices that can measure pulse pressure.
Additionally, MATLAB, a numerical computing software, can be used to analyze pulse pressure data.
When it comes to pulse pressure research, it's important to have access to the best protocols and products.
PubCompare.ai's AI expertise can help researchers seamlessly locate the most effective protocols from literature, preprints, and patents.
This allows researchers to identify the most appropriate protocols and products for their specific needs, ultimately enhancing the quality and impact of their pulse pressure research.
In addition to the SphygmoCor system and MATLAB, researchers may also utilize devices like the HEM-9000AI and HEM-907XL to measure blood pressure and calculate pulse pressure.
By leveraging a variety of tools and technologies, researchers can optimize their pulse pressure research protocols and gain valuable insights into cardiovascular health and function.
Overall, pulse pressure is a critical metric that provides important information about the cardiovascular system.
By utilizing the right tools and protocols, researchers can deepen their understanding of this key physiological measure and develop more effective treatments for cardiovascular conditions.
Elevated pulse pressure is associated with increased risk of heart attacks, strokes, and other cardiovascular events.
Optimizing pulse pressure research protocols is essential for developing effective treatments.
Researchers can utilize various tools and technologies to measure and analyze pulse pressure.
The SphygmoCor system, for example, is a widely used device that provides accurate pulse pressure measurements.
The SphygmoCor XCEL and VaSera VS-1000 are other devices that can measure pulse pressure.
Additionally, MATLAB, a numerical computing software, can be used to analyze pulse pressure data.
When it comes to pulse pressure research, it's important to have access to the best protocols and products.
PubCompare.ai's AI expertise can help researchers seamlessly locate the most effective protocols from literature, preprints, and patents.
This allows researchers to identify the most appropriate protocols and products for their specific needs, ultimately enhancing the quality and impact of their pulse pressure research.
In addition to the SphygmoCor system and MATLAB, researchers may also utilize devices like the HEM-9000AI and HEM-907XL to measure blood pressure and calculate pulse pressure.
By leveraging a variety of tools and technologies, researchers can optimize their pulse pressure research protocols and gain valuable insights into cardiovascular health and function.
Overall, pulse pressure is a critical metric that provides important information about the cardiovascular system.
By utilizing the right tools and protocols, researchers can deepen their understanding of this key physiological measure and develop more effective treatments for cardiovascular conditions.